Edition:
United States

Intrexon Corp (XON.N)

XON.N on New York Stock Exchange

12.85USD
17 Nov 2017
Change (% chg)

$-0.77 (-5.65%)
Prev Close
$13.62
Open
$13.51
Day's High
$13.63
Day's Low
$12.59
Volume
252,452
Avg. Vol
255,286
52-wk High
$31.85
52-wk Low
$10.26

Latest Key Developments (Source: Significant Developments)

Intrexon posts Q3 qtrly ‍net loss per share $0.33​
Thursday, 9 Nov 2017 04:05pm EST 

Nov 9 (Reuters) - Intrexon Corp :Intrexon announces third quarter 2017 financial results.Q3 revenue $46 million versus I/B/E/S view $55.1 million.Intrexon corp - qtrly ‍net loss per share $0.33​.Q3 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S.  Full Article

Agilis Biotherapeutics announces orphan product designation approval in Europe for the treatment of friedreich ataxia
Tuesday, 31 Oct 2017 07:30am EDT 

Oct 31 (Reuters) - Agilis Biotherapeutics :Agilis Biotherapeutics announces orphan product designation approval in Europe for the treatment of friedreich ataxia.‍agilis Biotherapeutics says EC granted orphan medicinal product designation in EU to company's gene therapy product candidate, AGIL-FA​.‍agilis Biotherapeutics says company has completed a pre-IND meeting with FDA and is on track to open an IND in 2018​.  Full Article

Intrexon and Arch Pharmalabs collaborate on fermentative production of an API to replace existing process sourced from animals
Monday, 23 Oct 2017 08:00am EDT 

Oct 23 (Reuters) - Arch Pharmalabs Ltd :Intrexon and Arch Pharmalabs collaborate on fermentative production of an API to replace existing process sourced from animals.Intrexon Corp - ‍Arch Pharmalabs will have exclusive access to co's technologies for fermentation-based production of specific API.Intrexon - Will receive technology access fee, milestone payments, as well as a 40% royalty based on gross profit of commercialized products.  Full Article

Intrexon enters into $100 mln preferred stock equity facility
Monday, 16 Oct 2017 04:13pm EDT 

Oct 16 (Reuters) - Intrexon Corp :Intrexon Corporation enters into $100 million preferred stock equity facility.Intrexon Corp - ‍under facility, Intrexon may, at its discretion, sell to investor up to $100 million of newly issued series a redeemable preferred stock​.  Full Article

OXITEC SAYS FRIENDLY AEDES REGULATORY JURISDICTION TRANSFERRED
Wednesday, 4 Oct 2017 01:00pm EDT 

Oct 4 (Reuters) - Oxitec::SAYS AFTER GUIDANCE ISSUED BY U.S. FDA-CVM, REGULATORY JURISDICTION FOR OXITEC'S FRIENDLY AEDES MOSQUITO WILL NOW MOVE UNDER EPA AS PESTICIDE PRODUCT ​.  Full Article

Intrexon files for potential mixed shelf size not disclosed - SEC filing‍​
Friday, 1 Sep 2017 05:35pm EDT 

Sept 1 (Reuters) - Intrexon Corp :Files for potential mixed shelf; size not disclosed - SEC filing‍​.  Full Article

Intrexon Q2 loss per share $ 0.16
Wednesday, 9 Aug 2017 04:05pm EDT 

Aug 9 (Reuters) - Intrexon Corp :Intrexon announces second quarter and first half 2017 financial results.Q2 revenue $54.4 million versus I/B/E/S view $57.2 million.Qtrly loss per share $ 0.16.  Full Article

Intrexon, Johnson Matthey collaborate on production of peptide-based pharmaceutical ingredients
Tuesday, 13 Jun 2017 07:00am EDT 

June 13 (Reuters) - Intrexon Corporation::Intrexon and Johnson Matthey collaborate on fermentative production of peptide-based active pharmaceutical ingredients.Under terms, JM will have access to co's technologies and expertise for microbe-based fermentative production of specific target apis.Agreement also provides for milestone payments to Intrexon, as well as royalties based on net sales of commercialized products.Intrexon Corporation says Intrexon will receive a technology access fee and reimbursement for all research and development costs.Through collaboration, co to utilize proprietary microbial hosts, fermentation processes for expression of peptides with high fidelity, titer.  Full Article

Aquabounty acquires fish farming facility in Indiana
Tuesday, 13 Jun 2017 07:00am EDT 

June 13 (Reuters) - Aquabounty Technologies ::Aquabounty acquires fish farming facility in Indiana.Deal for ‍$14.0 million​.‍Aquabounty continues to evaluate additional opportunities for larger production facilities in both United States and Canada​.Once fully operational, current facility will have an expected annual capacity of 1200 metric tons.Entered into agreement to purchase certain assets of Bell Fish Company, including its farming facility in Albany, Indiana​.If anticipated timelines for deal are achieved, fish farming facility's first harvest could come as soon as Q3 of 2019.  Full Article

Intrexon posts Q1 revenue $53.7 million
Wednesday, 10 May 2017 04:05pm EDT 

May 10 (Reuters) - Intrexon Corp :Intrexon announces first quarter 2017 financial results.Q1 revenue $53.7 million versus I/B/E/S view $49.1 million.Intrexon Corp - Qtrly net loss per share, basic and diluted $0.26.Q1 earnings per share view $-0.24, revenue view $49.1 million -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Intrexon posts Q3 qtrly ‍net loss per share $0.33​

* Q3 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: